Spots Global Cancer Trial Database for Impact of HPV Vaccine On The Prevalence Of HPV In Norway

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Impact of HPV Vaccine On The Prevalence Of HPV In Norway

Official Title: Impact of HPV Vaccine On The Prevalence Of Human Papillomavirus In Mouth And Vagina In Norway

Study ID: NCT02934724

Conditions

Cervical Intraepithelial Neoplasia

Cervical Cancer

Oropharyngeal Cancer

Interventions

Self sample from vagina

Self sample from the oral cavity

Questionnaire

Study Description

Brief Summary: The overall aim of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997. Women born in 1997, residence to Norway in 2009 (the year of vaccine initiation of the 1997-cohort) are invited to participate in the study.

Detailed Description: This cohort is amongst the first that was offered HPV vaccine in an organized vaccination programme globally. The women will be recruited through Facebook ads. The study will enable us to measure differences in the prevalence of HPV types in vagina and the mouth between vaccinated and non-vaccinated young women in Norway. The womens vaccination status will be validated by linkage to the Norwegian Immunisation Registry (SYSVAK) and their residence status will be validated through linkage to the Norwegian Population Registry.